p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer

Int J Mol Sci. 2019 Nov 17;20(22):5781. doi: 10.3390/ijms20225781.

Abstract

Skin cancer is the most common type of cancer worldwide. Ozone depletion and climate changes might cause a further increase in the incidence rate in the future. Although the early detection of skin cancer enables it to be treated successfully, some tumours can evolve and become more aggressive, especially in the case of melanoma. Therefore, good diagnostic and prognostic markers are needed to ensure correct detection and treatment. Transcription factor p63, a member of the p53 family of proteins, plays an essential role in the development of stratified epithelia such as skin. In this paper, we conduct a comprehensive review of p63 expression in different types of skin cancer and discuss its possible use in the diagnosis and prognosis of cutaneous tumours.

Keywords: Merkel cell carcinoma; basal cell carcinoma; p40; p63; skin cancer; squamous cell carcinoma.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Carcinoma, Basal Cell / diagnosis*
  • Carcinoma, Basal Cell / metabolism
  • Carcinoma, Squamous Cell / diagnosis*
  • Carcinoma, Squamous Cell / metabolism
  • Humans
  • Immunohistochemistry
  • Melanoma / diagnosis*
  • Melanoma / metabolism
  • Prognosis
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / metabolism
  • Transcription Factors / metabolism*
  • Tumor Suppressor Proteins / metabolism*

Substances

  • Biomarkers, Tumor
  • TP63 protein, human
  • Transcription Factors
  • Tumor Suppressor Proteins